Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your first visit or hospital stay at the study centre happened (or will happen) between September 2023 and September 2028
- You have been diagnosed with non-small cell lung cancer (a common type of lung cancer), at any stage
Who may not be able to join:
- Your cancer has been diagnosed as coming from an uncertain or unknown origin, meaning doctors are not sure it originally started in the lung
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Alessandro Del Conte, MD, Centro di Riferimento Oncologico di Aviano (CRO) - IRCCS
Phone: 0434 399464
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To evaluate the frequency of patients with oncogene addiction in a consecutive series of patients afferent to the CRO with NSCLC.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.